Nurix Therapeutics Inc

NRIXNASDAQ NMS - GLOBAL MARKET

Health CareBiotechnology

$17.76

+0.0900 (+0.51%)

As of 05/29/26 EDT · USD

Compare

52-Week Low: $8.20Current: $17.7652-Week High: $22.50

Key Statistics

Open

$17.67

Day High

$18.00

Day Low

$17.56

Prev. Close

$17.67

Volume

1.09M

Avg. Volume

—

Market Cap

$1.84B

P/E (TTM)

-5.62

Forward P/E

—

P/B Ratio

—

52W High

$22.50

52W Low

$8.20

50D MA

$16.24

200D MA

$14.62

Dividend Yield

—

Beta

—

Performance

+1.3%

+6.9%

+4.5%

YTD

-1.7%

+46.3%

About

Targeted protein degradation (TPD) is a drug design strategy that uses small molecules such as PROteolysis TArgeting Chimeras (PROTACs), molecular glues, or related approaches to induce the selective ubiquitination and subsequent proteasomal degradation of target proteins via the ubiquitin–proteasome system or other cellular clearance pathways. Unlike traditional occupancy-driven inhibition, TPD agents catalytically trigger irreversible loss of disease-modifying proteins, enabling the removal of providing sustained duration of action after transient engagement of the target protein. This event-driven approach is being investigated for potential therapeutic applications in oncology, neurodegeneration, and other areas.

www.nurixtx.com/